Image source: The Motley Fool.
CytomX Therapeutics, inc (NASDAQ: CTMX)
Q2 2021 Earnings Call
Aug 6, 2021 , 5:00 p.m. ET
Operator
For further details see:
CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call TranscriptImage source: The Motley Fool.
CytomX Therapeutics, inc (NASDAQ: CTMX)
Q2 2021 Earnings Call
Aug 6, 2021 , 5:00 p.m. ET
Operator
For further details see:
CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
Market:
SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced the first patient has been dosed in a Phase 1 dose escalation study ( NCT06265688 ) of CX-2051 in pa...
- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved in the collaboration to date - - CytomX-retains US co-commercialization and economic rights for select programs - SOUTH SAN FRANCISCO, Calif., ...
SOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally ...